Neuromodulative actions of cytokines. by Blatteis, C. M.
THE YALE JOURNAL OF BIOLOGY AND MEDICINE 63 (1990), 133-146
Neuromodulative Actions ofCytokines
CLARK M. BLATTEIS, Ph.D.
Department ofPhysiology andBiophysics, College ofMedicine, University of
Tennessee, Memphis, Memphis, Tennessee
Received June 8, 1989
Interleukin 1, interferon a2, and tumor necrosis factor a are cytokines that centrally mediate
various reactions typical of the host defense responses to infection. The preoptic-anterior
hypothalamus is an important, but not exclusive, integrative and controlling region for several of
theseeffects. Althoughthesecytokinesdisplaysomecommon functionalactivities (e.g.,pyrogenic-
ity, somnogenicity), the characteristics of the responses they induce are different. Their effects,
moreover, can be evoked orsuppressed selectively, indicating that the neuronal substrates and/or
neuromodulators used are distinct, each possessing discrete but partially overlapping sensory
combinations. Nevertheless, it is not yet obvious how these systems are organized and integrated
in host defense. It is also unclear whether these cytokines are elaborated peripherally and gain
access to the brain or whether they are induced centrally. The available data suggest that
circulating cytokines probably do not penetrate the brain but may activate elements in the
organum vasculosum laminae terminalis. This site appears to be critically important for the
production of the centrally mediated effects of blood-borne cytokines; it is speculated that the
cytokines evoke there local signals that transduce their message; serotonin may be linked to these
signals.
Fever is the most manifest and best known sign ofinfection [1]. Infected animals of
many species characteristically exhibit an array of other signs as well, however,
including increases (e.g., acute-phase proteins, copper) or decreases (e.g., albumin,
iron) in the concentrations of various plasma constituents, neutrophilic leukocytosis,
increased sleepiness, reduced appetite, hyperinsulinemia and hyperglucagonemia with
consequent alterations in blood glucose levels, changes in the circulating levels of
certain pituitary peptides (e.g., adrenocorticotropic hormone), and enhancement of
certain immune functions [2-4]. It is well known that fever is a centrally regulated
response, induced by the action, predominantly in the preoptic area of the anterior
hypothalamus (POA), of endogenous substances liberated primarily by activated
mononuclear phagocytes, but also by many other cell types. Originally, these sub-
stances were thought to be but one, and it was called leukocytic pyrogen (LP) [5].
Today, we know that LP was a mixture of factors belonging to a class now termed
cytokines, produced bycells ofthe immunesystem. Indeed, severalcytokines have been
shown to be pyrogenic: interleukin 1 (IL-1), tumor necrosis factor a (TNF), interferon
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a2 (IFN), interleukin 6 (IL-6), and macrophage inflammatory protein 1 [6-9]; IL-1
exists in two biochemically distinct forms, a and f,, which share many, but not all, of
each other's bioactivities [2]. We now know, in addition, that these cytokines also
mediate various other systemic responses typical ofinfection, and lately it has become
apparent that several of these, too, are mediated centrally. Indeed, that the central
nervous system (CNS) plays a major role in the modulation of host defense responses
against infection is no longer in doubt [10].
The purpose of this paper is to review briefly what is currently known regarding the
sites and modes of actions in the brain of these cytokines/endogenous pyrogens in
prompting their multiple responses. IL-6 and macrophage inflammatory protein 1,
however, will not be considered in this context, as they have as yet been insufficiently
studied.
IMMUNE SIGNAL TRANSDUCTION BY THE BRAIN
Since endogenous pyrogens are thought to be produced peripherally and since,
moreover, theirintravenous (iv) injectioninducesfever, acentrallyregulatedthermoreg-
ulatory response, after a relatively short latency, it hasgenerally been assumed that the
effective cytokines are released systemically and transported to the brain by the blood.
It has not yet been possible, however, to demonstrate that endogenous pyrogens cross
the blood-brain barrier and localize in any brain site. Indeed, being water-soluble
peptides, cytokines would not be expected to cross the blood-brain barrier readily
without specific carrier systems, of which, so far, none have been identified. But the
cytokines might pass into the brain through the circumventricular organs, which have
no blood-brain barrier [11]; to wit, the organum vasculosum laminae terminalis
(OVLT) and the area postrema are located close tocytokine-sensitive, fever-producing
sites in the medial preoptic area and the medulla oblongata (MO), respectively (see
below). Indeed, we showed [12,13] in guinea pigs and sheep that ablation of the
vascular plexus of the OVLT, in the anteroventral third ventricular wall (AV3V),
results in thesuppression ofthefeverand acute-phaseproteinemia evoked by intraperi-
toneally (ip) administered lipopolysaccharide (LPS). But in rats and rabbits, on the
other hand, Stitt [14] found that small lesions of the ventrorostral OVLT transiently
enhance the febrile responsiveness to semipurified IL-I given iv. Very recently,
however, we found again [15] that AV3V lesions attenuate the fevers caused in guinea
pigs not only by ip injected LPS, but also by iv injected LPS, IL-1f, IFN, and TNF.
Destruction of the AV3V did not affect the pyrogenic sensitivity to intrapreoptically
(iPO) injected IL-I [12] or the normal thermoregulation of these animals [16]. Thus,
these data indicate that the integrity of the vascular plexus of the OVLT is critically
important for the induction ofcentrally mediated responses to systemically elaborated
orinjected cytokines. One might then presume that the lackofa blood-brain barrier at
this site would allow circulating endogenous pyrogens to pass through the fenestrated
endothelium and perivascular spaces into the clefts of the OVLT. It is not clear,
however, how these substances would penetrate deeper into the neuropil since tight
junctions surround the OVLT interstitium, preventing free diffusion into the POA or
adjacent third ventricle. Indeed, no IL-I has as yet been detected in the hypothalamus
ofrabbits [17] or in the ventricular cerebrospinal fluid (CSF) ofcats [18] at any stage
oftheir febrile courseafter ivadministered pyrogens. We, too [19], havebeen unable to
find any trace of human recombinant (hr) 1251-IL-la anywhere within the brains of
guinea pigs 5 to 60 minutes after injection ofpyrogenic doses ofthis compound into an
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internal carotid. Thus, circulating cytokines may not actually pass into the neuropil,
but rather may activate certain critical elements contained within the OVLT that, in
turn, may evoke secondary signals'that transduce their message. It has been proposed
that prostaglandin (PG) E, which is pyrogenic when applied locally into the POA, may
be such a second mediator [20]. A possible target ofcirculating IL-I could be certain
mesenchymally derived phagocytic cells reportedly extant within the perivascular
space of the OVLT, which presumably are capable of releasing PGE [14]. Since this
lipophilic molecule is able to diffuse across the blood-brain barrier [21], an alternative
target of IL-I could be the endothelial cells of the OVLT; endothelial cells release
prostanoids in response to fentomolar concentrations of IL-I within seconds after
exposure. interestingly without demonstrable IL-I-specific receptor binding [22].
Whatever the source ofthe PGE, a difficulty with the concept is that the diffusion time
ofPGE from the OVLT to the POA is longer than the latencyofthe febrile response to
IL-I given iv; however, PGE could act initially and directly on neurons in the OVLT.
Indeed, Stitt [20] has reported that the OVLT regionofrats ismarkedly moresensitive
to the pyrogenicaction ofPGE than is the POA. On the otherhand, wefound in guinea
pigs [23] that PGE and IL-1 in doses that are pyrogenic when administered into the
POA are ineffective when microinjected into the OVLT. Although this discrepancy
could beaccounted forsimply byspeciesdifferences, it isnoteworthy that IL-I-induced
phospholipase A2 appears later in vitro in fibroblasts ofrats [24] than theonsetoffever
following IL-1 in vivo in guinea pigs [23]. Since all the biological effects of the
cytokines are not modulated by PGE (see below), an alternative possibility could be
that the cytokines are somehow detected by sensory elements in the OVLT and
transduced into neuronal signals that are transmitted to the POA. In support, we
recently found [25] that certain OVLT neurons in brain slicepreparations from guinea
pigs were excited by hrTNF; these units also were excited by serotonin (5HT). 5HT
terminals are abundant in the OVLT and may, therefore, have a role in transmitting
these signals. It is conceivable that blood-borne cytokines could by this means induce
the release of glial [26-30; Bakouche and Lachman, this issue] and/or neuronal
[31-33] second messengers. Ifso, secondarily brain-synthesized rather than originally
evoked peripheral endogenous factors might be the ultimate central mediators of host
defense mechanisms. Since the induction of new cytokines is slow, these factors could
be different, locally stored neuromodulators; however, this and other possibilities
remain speculative at present.
LOCALIZATION OF CYTOKINE ACTIONS IN THE BRAIN:
THE PREOPTIC AREA
Fever
Evidence that discretebrain sites activatefebrigenic responses wasderived primarily
from studies in which cytokines were microinjected into various brain regions initially
selected on the basis of their demonstrated involvement in temperature regulation
(reviewed in [34]). Thus, such studies have established that IL-1, TNF, and IFN elicit
the most rapidly developing and most intense febrile responses when delivered into the
POA. Interestingly, however, the courses ofthe fevers eachcytokine evokes are distinct
[35]. Thus, the fevers produced by IL-1 are generally quick in onset, unimodal, and
relatively brief. Those induced by TNF, by contrast, are bimodal and somewhat
prolonged, while those caused by IFN, although unimodal, are more protracted and
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develop after longer latencies than those provoked by IL-1. The bases for these
differential patterns are not yet known, but they could be related to the involvement in
these responses of distinct second messengers and/or neuronal substrates (see below).
Acute-Phase Proteinemia
Many studies have established that perfused livers and primary cultures ofhepato-
cytes incubated with IL-I secrete acute-phase proteins into the medium [36], and it
has been shown that IL-I specifically modulates the pre-translational expression ofthe
genes for several proteins in human and rat hepatocytes [37]. In additon to this direct
effect, however, IL-I may also modulate acute-phase protein hepatic synthesis indi-
rectly through an action on the CNS. This possibility was originally suggested by
observations that intracerebroventricular (icv) injections of IL-I induce, in addition to
fever, several of the blood chemical changes typical of IL-I's effects following its
systemic administration [38,39]. We have shown that the locus of this central
mediation is also the POA [40]. Injections of IL-I into this site augment the plasma
levels of copper (hence ceruloplasmin, to which virtually all plasma copper is bound)
and of protein-bound N-acetylneuraminic acid (the terminal residue of most plasma
glycoproteins) similar to the responses induced by ip injection, although the iPO dose
was one orderofmagnitude smaller than the ip dose; such a small dose does not induce
either fever or hyperproteinemia when injected systemically. TNF and IFN do not,
however, share this activity with IL-1 when given centrally [41-43], although TNF
reportedly induces elevations of acute-phase protein plasma levels, both when given
peripherally and in vitro [44,45]. It was recently reported that the POA also mediates
the IL-I-induced leukocytosis ofrats [46].
Other HostDefense Responses
Further evidence of POA involvement in cytokine-mediated host defense responses
is provided by other demonstrations that the central administration ofmicroquantities
of cytokines enhances slow-wave sleep in rabbits [Krueger et al., this issue]; a
hypnogenic controller has been identified in, among other loci, the POA [47]. The iPO
administration of IL-I also induces a prompt hyperinsulinemia in anesthetized, fasted
rats [48], similar to its effect when given iv at ten times the dose, indicating that, in
addition to its direct modulating influence on pancreatic islets [49], it also induces a
signal in the hypothalamus for pancreatic insulin secretion. It has not yet been reported
whether the latter effect is also inducible centrally by TNF and IFN, and whether thus
evoked sleepiness and hyperinsulinemia survive OVLT lesions.
Extra-POA Sites: Persistence ofIL-I Effects After POA Lesions
Although the POA is the preeminent site driving the febrigenic and other responses
to IL-1, TNF, and IFN, these responses remain relatively unimpaired when the POA is
disconnected from the brain by various means (reviewed in [34,50,51-52]). These
results indicate, therefore, that additional sites exist outside the POA that are also
capable ofmediating these effects. Indeed, sites in which microinjections of IL-I evoke
fever have variously been localized in the lateral hypothalamus, midbrain reticular
formation, pons, and MO of guinea pigs and rabbits [23,53,54]; MO temperature-
sensitive units have also been shown to respond appropriately to locally applied crude
IL- [55,56]. The heights and durations of the febrile responses elicited from these
extra-POA loci progressively diminish, however, as their distance from the POA
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increases. Moreover, by microcutting each reactive site from its connections upstream
or downstream, then microinjecting IL-I above or below the cuts, we showed [57] that
the lateral hypothalamus and pons are not independent pyrogenic controllers because
IL-I injected locally into these sites did not induce fever when they were disconnected
from the POA above while connected to the thermoeffectors below. Only the MO
appeared capableofautonomouscontrol, asmicroinjectionofIL-I into this sitewhenit
was separated from the rest of the brain above still elicited fever [57]. The precise
boundaries of these various controllers and their functional interconnections are as yet
unclear. It is also not yet known whether any ofthese extra-POA fever-producing sites
are similarly capable of driving other acute-phase actions of the cytokines. Although
IL-I receptors are widely distributed throughout the brain [58], the injection of this
cytokine into the cerebellum or cortex does not produce pyrogenic effects (reviewed in
[34]); other possible effects have not yet been measured.
OTHER CENTRAL ACTIONS OF CYTOKINES
Food Intake
IL-I and TNF have also been implicated in cachexia. Their systemic administration
induces anorexia and weight loss [59-61], as occurs in infectious disease [62,63]. It
was recently reported [64] that icv injections of hrIL-lfl and hrTNF suppress
nighttime feeding and prandial drinking in rats. Glucose-sensitive neurons in the
lateral hypothalamic area thought to be involved in the regulation of food intake are
depressed by the electrophoretic application of these cytokines, consistent with the
functional data and suggestive ofthe participation ofhypothalamic feeding-associated
sites in the suppression offeeding by these factors. To what extent the decrease in food
intake may also be attributable to, for example, IL-1-induced hyperinsulinemia and
sleepiness, or to other immunomodulators that may be elaborated and provide regula-
tory signals to feeding cannot, however, be evaluated at present [65,66].
Neuroimmunoendocrine Responses
Recent evidence indicates that IL-I and TNF, but not IFN, modulate the secretion
of various pituitary peptides, including prolactin, growth hormone, thyrotropin-
releasing hormone, adrenocorticotropic hormone (ACTH), and luteinizing hormone-
releasing hormone [67-69]. It is currently under debate whether IL-I or TNF acts
directly on the pituitary cells or on the hypothalamic sites of their releasing factors to
produce these effects [70-72]. Their importance lies in that these peptides provide one
of the means by which the central nervous and immune systems may communicate
[73,74]. The precise brain loci of their actions are not yet known, but some recent
evidence suggests that the POA may be the site wherein IL-I and TNF initiate the
secretion ofcorticotropin-releasing factor (CRF) and that the OVLT may be involved
in this process [75,76; Saphier et al., this issue]. The neurons involved in this response
have not yet been characterized, but it has long been known that exogenous pyrogens
and thermal stimulation of the POA evoke elevations of plasma glucocorticoids,
thereby implicating thermosensitive units in this effect [77,78]. Furthermore, there is
evidence in rabbits that cortisone, ACTHI_24, and CRF may participate in antipyresis
[79], while in rats, by contrast, IL-il,-induced fever may require CRF [80]. The
antipyretic activity of ACTH may, in fact, be due to a fragment of ACTH,-24,
a-melanocyte-stimulating hormone or ACTH 13, which not only blocks the fever, but
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also the acute-phase hyperproteinemia [81; Lipton, this issue], somnogenesis [81], and
certain inflammatory and immune effects ofIL-1 [87].
NEURAL BASIS OF CYTOKINE ACTIONS
Neural Connections Involved in IL-I Actions
There is some evidence that the ventromedial hypothalamus (VMH) may contain
fibers ofpassage that modulate IL-I effects, as horizontal separation ofthe POA from
the VMH attenuates the fevers produced bysystemic injections ofexogenous pyrogens
[83]; PGE and IL-1 microinjected into the VMH, however, do not evoke thermal
responses [23]. The posterior hypothalamus also seems necessary for fever production,
since its destruction abolishes the febrile response to systemic pyrogens [84]; however,
direct injection of IL-1 into the posterior hypothalamus does not elicit a febrile
response [53,85,86].
Neuronal Correlates ofthe Functional Effects ofthe Cytokines
The POA and MO, among other brain regions, contain neurons that are sensitive to
small changes in their local temperatures [87]. Two types have been identified:
warm-sensitive neurons, the firing rates of which increase with local warming and
decrease with local cooling, and cold-sensitive neurons, the firing rates of which,
conversely, increase with localcoolinganddecreasewith local warming. Thedirections
of the changes in the electrical activities ofthese neurons are well correlated with the
thermoeffector responses induced by the relevant stimuli; i.e., excitation of warm-
sensitive neurons is associated with heat loss responses, while that of cold-sensitive
neurons is associated with heat production responses. Consistent with the diminished
heatloss andenhanced heatproduction thatunderliethedevelopmentoffever [88], the
febrile rise induced by each of the three cytokines under review is associated with
decreased activity ofwarm-sensitive and increased activity ofcold-sensitive neurons in
the POA and MO [89; Shibata, this issue]. It is not yet clear, however, whether these
units are the direct targets of the cytokines. Thus, although localized cooling of the
POA induces thermoregulatory responses typical of fever, this effect cannot be
construed as evidence that thecytokines actspecifically onthe warm orcold population
of thermosensitive units. Indeed, a significant proportion of thermoinsensitive units is
also affected by these cytokines [Shibata, this issue]. Interestingly, few individual
neurons exposed in vitro to all three cytokines or to PGE respond identically to all, or
even to any two, of these substances [35,90; Shibata, this issue]. The thermosensitive
neurons in the POA do not appear to be involved, however, in the control of the
acute-phase protein response to IL-1; viz., POA cooling or heating does not induce any
change in the plasma levels of acute-phase reactants [91]. These results suggest,
therefore, that thecentral actions ofIL-I intiating these nonfebrile acute-phase effects
do not involve the thermosensitive neurons in the POA. Hence, the units postulated to
be driving the febrile and these nonthermal responses to IL-I are distinct. Thermosen-
sitiveunits may, however, beimplicated in the IL-I- and TNF-induced neuroendocrine
response; viz., it has long been known that hypothalamic heating or cooling, as well as
the administration of pyrogens increases the secretions of, among others, ACTH and
glucocorticoids [77,78]. Some evidence also exists showing that preoptic thermosensi-
tive neurons may be involved in immunostimulation: both heating and cooling of the
POA cause elevated antibody titers [92,93]. These responses occur independently of
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the direction of body temperature changes [94], however, and only the primary
humoral immune response is affected [95]. Similarly, both localized preoptic heating
and stimulation with capsaicin (which specifically excites warm-sensitive neurons
[96]) induce slow-wave sleep-like electroencephalographic synchronization in rats
[47,97,98]; these results are consistent with the sleepiness often experienced in
moderately warm environments. But the neurons facilitated in this instance, i.e.,
warm-sensitive neurons, are generally inhibited by the cytokines, albeit these factors
are somnogenic. This paradox further illustrates the variety and distinctiveness of
neurons sensitive to these cytokines.
Lately, preopticthermosensitiveneurons havealsobeen found tobeosmo-, reproduc-
tive hormone-, and glucose-sensitive [99,100]. It is thus possible that theintegration of
host defense responses is accomplishedthrough theactivation ofa neuronalcircuit that
permits interactions among these multivariate functions.
PUTATIVE MEDIATORS OF THE CENTRAL ACTIONS OF CYTOKINES
Various neurochemical substances that influence, in particular, the febrile response
to cytokines have been identified [101,102]. Little is known about the central media-
tors of the other responses. In general, both facilitatory and inhibitory factors operate
in the overall modulation oftheir effects, but their precise modes ofinvolvement, singly
or in concert, have not yet been ascertained.
Eicosanoids
Several lines of evidence suggest that PGE may mediate the febrigenic action of
cytokines on POA thermosensitive units [20,77,103-105]. For instance, PGE microin-
jected icv or iPO in vivo is febrigenic and generally depresses the firing rates of
warm-sensitive and augments those ofcold-sensitive neurons, analogous to the actions
of the cytokines. Moreover, all three cytokines stimulate PGE synthesis by hypotha-
lamic tissue in vivo [105] and in vitro [106-108]; however, these effects could be
artifactual [109]. Difficult to reconcile also are findings that PGE applied iontophoret-
ically in vivo [110] or added to slice preparations in vitro [90,111] facilitates the
electrical activities of most neurons, regardless of their thermal specificity, and that
PGE and IL-I also often produce disparate responses in the same neuron [90]. These
results would seem inconsistent with the hypothesis that cytokines affect fever-
producing neuronal activity through the mediation of PGE. On the other hand, the
antipyretic activity of PGE synthetase inhibitors, e.g., aspirin and indomethacin, is
well documented, albeit their central administration does not consistently block fever
[112]. It should be noted in this regard that although PGE is undoubtedly released by
POA slices incubated with cytokines, it is also produced in response to various other
agents, the reported in vivo thermoregulatory effects of which are not consistently
hyperthermogenic, e.g., norepinephrine, 5HT, acetylcholine, angiotensin II, and hista-
mine [113,114]. Furthermore, posterior hypothalamus and cortical slices also yield
PGE in response to these agents, although their injections into these brain regions do
not evoke thermal responses. Thus, the release of PGE from the POA may be a
nonspecific response to a variety of stimuli, and its role in fever production remains
ambiguous.
It has been suggested that other prostanoids may mediate cytokine-induced fever
[115,116]. Indeed, PGD2, F2,, and I2 and thromboxane A2 are all secreted by POA
slices incubated with IL-I in parallel with PGE [117]. The core temperature rises
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provoked by their iPO administration are not, however, similar in latency, height,
duration, or course to those produced by IL-1, thereby seemingly precluding their
direct participation in the response to IL-1 [23], although they might have a role in the
response to TNF or IFN. The latter has not yet been examined.
The leukotrienes B4, C4, D4, and E4, similarly, do not appear to participate in the
brain events initiating fever, as their intrapreoptic injection does not evoke fever-like
body temperature rises [118,119].
Neither the PGs nor the leukotrienes are involved in the central mediation of
acute-phase proteinemia, whether induced by the systemic [120,121] or central
[40,119,122] administration ofIL-1.
Other central effects induced by IL-I and TNF, e.g., somnogenesis and anorexia, are
also activated without the intermediation of PGE [61,123]. Similarly, conflicting
results have been reported regarding the role of PGE in the enhanced pancreatic
secretion of insulin evoked by the central administration of IL-1 [48,124] and the
releases ofhypothalamic CRF and pituitary ACTH [125,126].
It would seem, therefore, that the diverse actions of these cytokines are not
universally mediated by PGE. Hence, separate central mechanisms may operate in
regulating their individual effects.
Opioid Peptides
Studies on a possible role of the endogenous opioids in fever production have been
prompted by findings that f3-endorphin and various other opioid peptides are pyrogenic
when microinjected in low doses into the POA [127], and that increases in CSF and
hypothalamic tissue levels of f3-endorphin occur during endotoxin- and IL-1-induced
fevers in rabbits and sheep [128,129]. But, on the other hand, it has been reported that
low doses of naloxone injected iv or into the third ventricle do not alter the subsequent
febrile responses to iv IL-1 in cats and rabbits [130,131] or to iv LPS and icv
arachidonic acid, PGE, and PGI2 in rabbits and guinea pigs [132,133]. Since naloxone
at low doses, however, is primarily aIu-receptor antagonist, we [134] investigated
whethera and/or K receptors might be involved in fever production. Although the
6-agonist D-(ala2)-met-enkephalinamide and the K-agonist dynorphin A injected di-
rectly into the POA of conscious guinea pigs produced, like the,u-agonist morphine,
rises in body temperature, the courses of these responses differed from those produced
by iPO injections of IL-1; but viewed in retrospect, the courses resembled those
produced by TNF and IFN. Indeed, it was recently reported [135] that naloxone
blocks the IFN-induced activity of preoptic thermosensitive neurons, suggesting that
IFN may exert its febrigenic action partly through opiate receptors. In support, we
found [136] that naloxone administered subcutaneously in high doses, such that its
opiate receptor blocking effect is more generalized, inhibited the unimodal fever
produced by iv hrIFN, prevented the first body temperature rise of the bimodal febrile
response to hrTNF and reduced the second, and attenuated the first and suppressed the
second of the two-peaked response to LPS; the effect of naloxone on hrIL-1-induced
fever was not tested in these experiments. These results suggest, therefore, that two
processes may mediate the pyrogenic effects of these cytokines, viz., an endogenous
opioid- and a PGE-dependent mechanism, but it remains to be established where these
mechanisms operate and how they interact.
Interestingly, natural human purified IL-l,B and IFN also reduce the specific
binding of opioid agonists to their receptors in various brain regions [137,138]. The
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significance of these findings is still obscure, but opioids have been implicated in the
central modulation of, in addition to body temperature, sleep, appetite, and immune
function, all of which are altered during infection. By contrast, the opioids do not
appear to have a role in IL-I-induced acute-phase proteinemia [134].
CONCLUSIONS
It is apparent that cytokines play an important intermediary role in the neuromodu-
lation of diverse host defense responses against infection, and that the POA is an
important integrative and controlling region of several cytokine-produced effects;
however, the origin of these cytokines-are they induced peripherally or centrally?-
remains enigmatic. Cytokines do not share all ofeach other's biological activities, and
those activities they do have in common often display distinctive characteristics,
suggesting differences in the modes ofaction ofthese cytokines. The various functions
that they mediate, moreover, are separable, evidently using distinct neuronal sub-
strates and neuromodulators. It would appear, therefore, that neurons sensitive to
cytokines may consist of different sets, with discrete, although partially overlapping,
sensitivities and effectors. The location and boundaries of specific neural controllers,
the organizaton of their interconnections, and the mechanisms of their activation in
integrating the individual components ofmultivariate, complex host defense responses
can, however, as yet only be tentatively described. Hence, much work remains in order
to establish in what ways these cytokines interact in the central control ofhost defense
responses to infectious pathogens.
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